Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126452) titled 'KAP Study on the Application of Anti-influenza Drugs (Baloxavir Marboxil/Oseltamivir/Peramivir) in Children by Healthcare Professionals/Parents' on June 9.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
Influenza
Intervention:
Healthcare professionals group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-05-03
Target Sample Size: Healthcare professionals group:350;Guardians group:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpro...